RecruitingEarly Phase 1NCT07403201

The Effect of Therapy Combination in PCOS With Dlbs 3233

The Effect of Combination Therapy Dlbs 3233 and Clomifen Citrate vs Clomifen Citrate on Homa ir, Maturation Follicle, and Menstrual Cycle in PCOS Cases at Muhammadiyah Asri Medical Center Hospital


Sponsor

Inlacinpenelitian

Enrollment

90 participants

Start Date

Dec 15, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

The effect of combination therapy dlbs 3233 and clomifen citrate vs clomifen citrate on homa ir, maturation follicle, and menstrual cycle in PCOS cases at Muhammadiyah Asri Medical Center Hospital


Eligibility

Sex: FEMALEMax Age: 45 Years

Inclusion Criteria1

  • married agree to join this research

Exclusion Criteria1

  • dis agree to join research

Interventions

COMBINATION_PRODUCTdlbs 3233 , clomifen citrat

combination theraphy


Locations(1)

RS AMC Yogyakarta

Yogyakarta, DIY, Indonesia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07403201


Related Trials